NOW vs PLTR: Which Is the Better Buy?

Side-by-side comparison of ServiceNow, Inc. and Palantir Technologies Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
ServiceNow, Inc. Β· Technology
$139.82
+16.2% upside to fair value
Med Conviction Grade A- High Quality
VS
Palantir Technologies Inc. Β· Technology
$189.67
+2.4% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
NOW has more upside to fair value (+16.2%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric NOW PLTR
Current Price $139.82 $189.67
Fair Value Estimate $162.50 $194.30
Upside to Fair Value +16.2% +2.4%
Market Cap $144.6B $435.5B
Forward P/E β€” β€”
EV / EBITDA 43.1x 139.9x
Price / Sales 9.8x 70.7x
Price / FCF 31.5x 135.3x
Revenue Growth YoY +24.0% +92.8%
Gross Margin 74.8% 84.8%
Operating Margin 11.4% 42.8%
Return on Equity 13.8% 37.5%
Dividend Yield 0% 0%
FCF Yield 3.17% 0.74%
Analyst Consensus Strong Buy Hold
Investment Thesis
NOW β€” ServiceNow, Inc.
ServiceNow provides a cloud-based enterprise workflow platform spanning IT service management, operations, employee workflows, CRM, AI orchestration and security. Business quality is high because its common data model, deeply embedded workflows and cross-department deployments create meaningful switching costs, while roughly 90% of the Fortune 500 use the platform and more than 85 billion workflo…
PLTR β€” Palantir Technologies Inc.
Palantir Technologies Inc. is a software infrastructure company founded in 2003 and headquartered in Denver that builds and deploys Gotham for intelligence and defense workflows, Foundry as a central data operating system for enterprises, Apollo for software delivery across environments, and its Artificial Intelligence Platform (AIP) for unified access to open-source, self-hosted, and commercial …
Accumulation Zones
Metric NOW PLTR
Zone Low $121.88 $145.73
Zone High $138.12 $165.16
In Buy Zone? No No
← NOW Research    PLTR Research β†’    All Research